Covalon Technologies Ltd COV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Contamination Protection Solution Highlights Covalon’s Presence at the Association for Vascular Access 2026 Annual Scientific Meeting
-
Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings
-
Covalon to Present at the 2026 Annual Smallcap Discoveries Conference After Reporting Revenue Growth of 20% and Gross Margin of 67%
-
Covalon Reports Fiscal 2026 Third Quarter Results
-
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2026 Results
Trading Information
- Previous Close Price
- CA$4.07
- Day Range
- CA$4.06–4.06
- 52-Week Range
- CA$1.55–4.59
- Bid/Ask
- CA$4.06 / CA$4.10
- Shares Outstanding
- 27.62M
- Market Cap
- CA$112.13M
- Volume/Avg
- 108 / 24,998
Key Statistics
- Price/Earnings (Normalized)
- 26.07
- Price/Sales
- 3.29
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes in the areas of infection management, wound care, and surgical procedures. The company generates revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products include IV dressings, surgical site protection products, vascular access protection products, and others, and its solutions include primary dressing cover, vascular access technologies, advanced wound care, sensitive skin solutions, custom medical coatings, and patient resource support.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.covalon.com
Valuation
|
Metric
|
COV
|
|---|---|
Price/Earnings (Normalized) | 26.07 |
Price/Book Value | 3.56 |
Price/Sales | 3.29 |
Price/Cash Flow | 19.65 |
Price/Earnings
COV
Financial Strength
|
Metric
|
COV
|
|---|---|
Quick Ratio | 6.51 |
Current Ratio | 8.56 |
Interest Coverage | — |
Quick Ratio
COV
Profitability
|
Metric
|
COV
|
|---|---|
Return on Assets (Normalized) | 13.24% |
Return on Equity (Normalized) | 15.73% |
Return on Invested Capital (Normalized) | 13.73% |
Return on Assets
COV
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|!<^yxsx | LOCK|#?J | $149B | |||
| Becton Dickinson & Co
BDX
| LOCK|N> | LOCK|?>>Kd | $51B | |||
| ResMed Inc
RMD
| LOCK|<??@g&t! | LOCK|p<fw! | $33B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|wPF<!cK | LOCK|NnsR# | $31B | |||
| Alcon Inc
ALC
| LOCK|<S>v%! | LOCK|@Fjm | $30B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|h#WDWzHt | LOCK|!b | $26B | |||
| Solventum Corp
SOLV
| LOCK|<>c<?w | LOCK|WzG | $15B | |||
| Baxter International Inc
BAX
| LOCK|wy$ | LOCK|ddCr | $13B | |||
| Repligen Corp
RGEN
| LOCK|^?^l$pT | LOCK|T%L$ | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|r<Q!!XQ | LOCK|$cBfV | $10B |
United States